06/18/2026
Idiopathic Pulmonary Fibrosis (IPF) is a devastating chronic disease characterized by progressive scarring of the lungs. Available treatments can slow the decline in lung function, but they cannot reverse the damage or restore healthy tissue. Because IPF is often diagnosed only after substantial scarring has occurred, researchers are seeking a better understanding of the cellular events that initiate and perpetuate the disease.
A new study published in Advanced Science, led by Dr. Brendon Baker, Associate Professor of Biomedical Engineering at the University of Michigan, examines a long-understudied participant in this process: the lung’s extensive network of blood vessels.
Read more: https://bme.umich.edu/2026/06/18/following-the-fibers-uncovering-a-vascular-clue-in-lung-fibrosis/